title: The effect of CTB on P53 protein acetylation and consequence apoptosis on MCF-7 and MRC-5 cell lines.
abstract: BACKGROUND
  P300 is a member of the mammalian histone acetyl transferase (HAT) family, an enzyme that acetylates histones and several non-histone proteins including P53 (the most important tumor suppressor gene) during stress, which plays an important role in the apoptosis of tumor cells. Hereby, this study describes the potency of CTB (Cholera Toxin B subunit) as a P300 activator to induce apoptosis in a breast cancer cell line (MCF-7) and a lung fibroblast cell line (MRC-5) as a non-tumorigenic control sample.
  
  
  METHODS
  MCF-7 and MRC-5 were cultured in RPMI-1640 and treated with or without CTB at a concentration of 85.43 μmol/L, based on half-maximal inhibitory concentration (IC50) index at different times (24, 48 and 72 h). The percentage of apoptotic cells were measured by flow cytometry. Real-time quantitative RT-PCR was performed to estimate the mRNA expression of P300 in MCF-7 and MRC-5 with CTB at different times. ELISA and Bradford protein techniques were used to detect levels of total and acetylated P53 protein generated in MCF-7 and MRC-5.
  
  
  RESULTS
  Our findings indicated that CTB could effectively induce apoptosis in MCF-7 significantly higher than MRC-5. We showed that expression of P300 was up-regulated by increasing time of CTB treatment in MCF-7 but not in MRC-5 and the acetylated and total P53 protein levels were increased more in MCF-7 cells than MRC-5.
  
  
  CONCLUSIONS
  CTB could induce acetylation of P53 protein through increasing expression of P300 and consequently induce the significant cell death in MCF-7 but it could be well tolerated in MRC-5. Therefore, CTB could be used as an anti-cancer agent.
authors: Department of Anatomical Sciences and Molecular Biology, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.
authors: Mehdi Nikbakht
authors: MN
authors: Dastjerdi
authors: Mohammad R
authors: MR
authors: Salahshoor
authors: Mohammad
authors: M
authors: Mardani
authors: Batool
authors: B
authors: Hashemibeni
authors: Shiva
authors: S
authors: Roshankhah
keywords: Acetylation; Cholera toxin B subunit; P300; P53; apoptosis
references: Int J Oncol. 2008 Oct;33(4):637-46
references: 18813776
references: Indian J Biochem Biophys. 2010 Dec;47(6):364-9
references: 21355420
references: Eukaryot Cell. 2008 Jul;7(7):1200-10
references: 18487348
references: Cell Res. 2007 Apr;17(4):324-32
references: 17372613
references: Cancer Genet Cytogenet. 2004 Apr 15;150(2):164-7
references: 15066326
references: BMJ. 2011 Jul 28;343:d4411
references: 21798968
references: Antiviral Res. 2010 Nov;88(2):207-16
references: 20816895
references: J Hematol Oncol. 2009 Jun 01;2:22
references: 19486511
references: Histol Histopathol. 2002 Apr;17(2):657-68
references: 11962765
references: Biochim Biophys Acta. 2010 Aug;1804(8):1635-44
references: 19931429
references: J Biol Chem. 2010 Sep 10;285(37):28553-64
references: 20587414
references: Exp Mol Pathol. 2010 Apr;88(2):256-64
references: 20097195
references: Semin Cancer Biol. 2009 Jun;19(3):165-71
references: 19429480
references: Nat Rev Genet. 2002 Jun;3(6):415-28
references: 12042769
references: J Cell Biochem. 2006 Feb 15;97(3):448-58
references: 16288459
references: J Cell Sci. 2001 Jul;114(Pt 13):2363-73
references: 11559745
references: Adv Cancer Res. 2009;102:171-95
references: 19595309
references: Am J Physiol Endocrinol Metab. 2010 Jan;298(1):E127-37
references: 19903865
references: Nat Rev Cancer. 2010 Jun;10(6):415-24
references: 20495575
references: Prostate. 2008 Jul 1;68(10):1097-104
references: 18459105
references: Aging (Albany NY). 2011 Feb;3(2):162-7
references: 21307403
references: J Phys Chem B. 2007 May 3;111(17):4527-34
references: 17417897
references: Mol Cell Biol. 2005 Aug;25(15):6592-602
references: 16024795
references: J Biol Chem. 2003 Apr 11;278(15):13431-41
references: 12499368
references: Asia Pac Fam Med. 2008 Dec 20;7(1):6
references: 19099595
references: Nucleic Acids Res. 2010 Aug;38(15):4970-84
references: 20385574
references: J Hematol Oncol. 2010 Feb 04;3:5
references: 20132536
references: Oncogene. 2009 Feb 12;28(6):781-91
references: 19060927
references: Epigenetics. 2010 Jan 1;5(1):9-15
references: 20110770
references: J Mol Biol. 2004 Apr 16;338(1):17-31
references: 15050820
references: Oncogene. 2004 May 24;23(24):4225-31
references: 15156177
references: Genes Dev. 2000 Jul 1;14(13):1553-77
references: 10887150
references: J Mol Biol. 2008 Feb 8;376(1):8-12
references: 18155245
references: Drug Resist Updat. 2011 Feb;14(1):35-44
references: 21195657
references: Cancer Res. 2006 Apr 15;66(8):4368-77
references: 16618762
references: Am J Transl Res. 2011 Feb;3(2):166-79
references: 21416059
references: Cell. 1997 Aug 22;90(4):595-606
references: 9288740
references: J Clin Invest. 2010 Feb;120(2):545-58
references: 20071779
references: Cell Res. 2007 Mar;17(3):195-211
references: 17325692
references: Nucleic Acids Res. 2008 Mar;36(5):1713-22
references: 18263614
references: PLoS One. 2010 Jan 13;5(1):e8369
references: 20084294
references: Trends Endocrinol Metab. 2006 Jul;17(5):186-91
references: 16684606
references: J Mol Med (Berl). 2003 Sep;81(9):549-57
references: 12920522
references: World J Gastroenterol. 2008 Aug 14;14(30):4810-5
references: 18720545
references: J Biomed Biotechnol. 2011;2011:603925
references: 21188172